Copyright
©2012 Baishideng. All rights reserved.
Endocannabinoid system: A newer molecular target for the treatment of alcohol-related behaviors
Basalingappa L Hungund, Division of Analytical Psychopharmacology, New York State Psychiatric Institute, New York, NY 10032, United States
Basalingappa L Hungund, Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY 10032, United States
Basalingappa L Hungund, K Yaragudri Vinod, Division of Analytical Psychopharmacology, Nathan Kline S. Institute for Psychiatric Research, Orangeburg, NY 10962, United States
K Yaragudri Vinod, Department of Child and Adolescent Psychiatry, New York University Medical Center, New York, NY 10016, United States
Author contributions: Hungund BL and Vinod KY both have contributed to this paper.
Supported by Funds from the National Institute of Health, Bethesda, United States; and American Foundation for Suicide Prevention
Correspondence to: Basalingappa L Hungund, PhD, Senior Research Scientist, Division of Analytical Psychopharmacology, Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Rd, Orangeburg, NY 10962, United States. hungund@nki.rfmh.org
Telephone: +1-845-3985452 Fax: +1-845-3985451
Received: July 27, 2011
Revised: January 7, 2012
Accepted: April 10, 2012
Published online: June 9, 2012
Revised: January 7, 2012
Accepted: April 10, 2012
Published online: June 9, 2012
Core Tip